Reaction
Tumour Marker Decreased reporting signals
As of the last recalculation, Tumour Marker Decreased appears in 179 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is ALPELISIB (PRR 351.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alpelisib | 23 | 351.9 | 352.8 |
| Ribociclib | 45 | 221.1 | 221.4 |
| Exemestane | 15 | 88.8 | 88.8 |
| Fulvestrant | 22 | 88.2 | 88.2 |
| Fam-Trastuzumab Deruxtecan-Nxki | 5 | 59.3 | 59.3 |
| Niraparib | 10 | 55.4 | 55.5 |
| Regorafenib | 5 | 51.5 | 51.5 |